Next, we examined the differences in clinicopathological characteristics such as tumor size, grade, lymph node status, lymphovascular invasion, the density of tumor-infiltrating lymphocytes, estrogen receptor, progesterone receptor, and HER2 status between the parous and nulliparous groups. This evidence concerns the gene PGR and neoplasm.